Stockreport

Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights

Traws Pharma, Inc.  (TRAW) 
PDF Merger with Trawsfynydd Therapeutics, Inc (“Trawsfynydd”) and concurrent private placement of $14 million (cash runway to support planned operations through year end), w [Read more]